Saul Carcamo

6PUBLICATIONS
84CO-AUTHORS
Haematological tumoursMedical mycologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2026
A CRISPR-Based Humanized Model Reveals Cooperative Role of STAG2 Loss in Familial GATA2-Deficient MDS Progression.

|Dec 06, 2025
Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia.

Ke Wang, Shayan Saniei, Nikita Poddar

|Mar 31, 2025
Cell-autonomous dysregulation of interferon signaling drives clonal expansion of SRSF2-mutant MDS stem/progenitor cells.

Kouhei Takashima, Malgorzata Olszewska, Vrinda Jethalia

|Oct 31, 2024
RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax.

Junya Sango, Saul Carcamo, Maria Sirenko

|Sep 07, 2023
p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 Expression.

Gizem Efe, Karen J Dunbar, Kensuke Sugiura

|Apr 17, 2023
Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia.

Andriana G Kotini, Saul Carcamo, Nataly Cruz-Rodriguez

Pageof 1

Frequent Collaborators

5 joint publications

Eirini P Papapetrou

5 joint publications

Dan Hasson

2 joint publications

Lewis Tomalin

2 joint publications

Isabella G Martinez